Search clinical trials for: KX2-391
Total 1015 results
-
Acorda TherapeuticsCompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Poland, Spain
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
TakedaCompletedHypertensionUnited States, Mexico, Chile, Peru
-
Uppsala UniversityKarolinska University Hospital; Uppsala University Hospital; Elicera TherapeuticsRecruiting
-
Livzon Pharmaceutical Group Inc.Active, not recruiting
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenCompletedGlucose Metabolism DisordersDenmark
-
University of VirginiaDexCom, Inc.; Tandem Diabetes Care, Inc.; Jaeb Center for Health ResearchCompleted
-
Diva De LeonTerminatedCongenital HyperinsulinismUnited States
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Trans Tasman Radiation Oncology...Completed
-
Betta Pharmaceuticals Co., Ltd.Completed
-
Chong Kun Dang PharmaceuticalCompleted
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Adult Non-Hodgkin LymphomaUnited States
-
Augusta UniversityYale University; University of Alabama at Birmingham; Tufts UniversityUnknownObesity | Diabetes | Insulin Resistance | Dyslipidemia | Insulin Sensitivity | PrediabetesUnited States
-
OncoC4, Inc.Merck Sharp & Dohme LLC; GOG FoundationRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of OvaryUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Pfizer; Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkins LymphomaUnited States
-
Albert Einstein College of MedicineCelldex TherapeuticsTerminatedLung Cancer | Non Small Cell Lung CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedColorectal Cancer | Metastatic CancerUnited States
-
Chong Kun Dang PharmaceuticalCompletedChronic Hepatitis BKorea, Republic of
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
National Cancer Institute (NCI)CompletedRecurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue SarcomaUnited States
-
Diabeteszentrum Bad Lauterberg im HarzCompleted
-
TakedaCompletedHypertensionUnited States, Argentina, Peru, Mexico
-
University of AarhusAarhus University Hospital; Central Denmark RegionCompletedTelemedicine | Triage | Emergency Medical ServiceDenmark
-
TakedaCompletedHypertensionUnited States, Mexico, Argentina
-
Kiniksa Pharmaceuticals, Ltd.CompletedGiant Cell ArteritisUnited States, Belgium, Croatia, Germany, Italy, Poland, Serbia, United Kingdom, Australia, Estonia, Ireland, Netherlands, New Zealand, Slovenia, Spain
-
Carmel BiosciencesAtlanta Vascular Research FoundationCompletedMetabolic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States, Canada
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Medical College of WisconsinTerminatedLeukemia, Myeloid, AcuteUnited States
-
Augusta UniversityYale University; University of Alabama at Birmingham; Tufts UniversityUnknownObesity | Insulin Resistance | Insulin Sensitivity | Prediabetes | Beta-Cell DysfunctionUnited States
-
Wroclaw Medical UniversityBoston Scientific CorporationRecruitingParoxysmal Atrial FibrillationPoland
-
Glenmark Pharmaceuticals Ltd. IndiaCompleted
-
NRG OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Unresectable Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Blasts More Than 10 Percent of Bone Marrow Nucleated CellsUnited States
-
Mayo ClinicCompletedPrimary Systemic AmyloidosisUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
TakedaCompletedEssential HypertensionChina
-
Acorda TherapeuticsCompleted
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University College, LondonCompleted
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; University of Sao Paulo and other collaboratorsActive, not recruitingHPV Infection | HIV-1-infection | HPV Positive Oropharyngeal Squamous Cell CarcinomaBrazil, Mexico, Puerto Rico
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenCompletedGlucose Metabolism DisordersDenmark
-
University of UlmJazz PharmaceuticalsRecruiting
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Belgium, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Taiwan
-
Jazz PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Canada
-
Tingbo LiuUnion hospital of Fujian Medical UniversityUnknown